Agoracom Blog

PyroGenesis $PYR.ca Announces Q2 2020 Results: Net Income $5.2MM; Gross Margin 60%; Earnings per Share $0.04 $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 8:57 AM on Wednesday, July 29th, 2020

Q2 2020 results reflect the following highlights:

  • Revenues of $2,128,454, an increase of 133% from $913,769 posted in Q2 2019
  • Comprehensive income of $5,228,020 an increase of 332% from ($2,253,390) posted in Q2 2020
  • Gross margin of 59.5% an increase of 39.2% over the same period in Q2 2019
  • Cash on hand on June 30, 2020 was $1,567,777 (December 31, 2019: $34,431)
  • Backlog of signed contracts as of the date of this writing is approx. $28MM.
  • Management expects significant revenue growth in 2020

MONTREAL, July 29, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to announce today its financial and operational results for the second-quarter ended June 30th, 2020.

“Percent complete revenue recognition in our major projects, which is the revenue recognition method we are mandated to follow by GAAP, is such that it is not linear, but exponential and as such, Q2 is now starting to reflect the results one might expect given recent announcements. It is interesting to note that using this revenue recognition method, only $1.8MM has been recognized under the $22MM+ DROSRITE™ contract for which we have announced receipt of over $7MM, and which will be completed within the next year. Using this same revenue recognition method, we can provide guidance for Q3 2020, and for the year ending December 31st, 2020: At this point, we expect that Q3 2020, and the nine months ending September 30, 2020, will both be profitable as will year end results. We are projecting Q3 2020 EPS (Basic & Diluted) to be conservatively in excess of 6 cents,” said P. Peter Pascali, CEO and President of PyroGenesis. “We are happy to be reporting these results in record time, and are pleased to note that we did so within the time frame set by more demanding exchanges. As such, we have set a goal to report all future financial results within the more stringent requirements set by the TSX as opposed to the TSXV.”

Q2 2020 results reflect the following highlights:

  • Revenues of $2,128,454, an increase of 133% from $913,769 posted in Q2 2019
  • Comprehensive income of $5,228,020 an increase of 332% from ($2,253,390) posted in Q2 2020
  • Gross margin of 59.5% an increase of 39.2% over the same period in Q2 2019
  • Cash on hand on June 30, 2020 was $1,567,777 (December 31, 2019: $34,431)
  • Backlog of signed contracts as of the date of this writing is approx. $28MM.

Management Guidance for Q3 2020

  • Management expects significant revenue growth
  • Management expects that Q3 2020 and the nine months ending September 30, 2020 to be profitable
  • Earnings per Share (EPS) > $0.06.

Management Guidance for full year 2020:

  • Management expects significant revenue growth in 2020
  • Earnings per Share (EPS) > $0.10.

OUTLOOK

Percent complete revenue recognition in our major projects, which is the revenue recognition method we are mandated to follow by GAAP, is such that it is not linear, but exponential and as such, Q2 is now starting to reflect the results one might expect given recent announcements. It is interesting to note that using this revenue recognition method, only $1.8MM has been recognized under the $22MM+ DROSRITE™ contract for which we have announced receipt of over $7MM, and which will be completed within the next year.

Using this same revenue recognition method, we can provide guidance for Q3 2020, and for the year ending December 31st, 2020: At this point we expect that Q3 2020, and the nine months ending September 30, 2020, will both be profitable as will year end results. We are projecting Q3 2020 EPS (Basic & Diluted) to be conservatively in excess of 6 cents and the year to be in excess of 10 cents. 

Any discussion regarding the OUTLOOK of the company would be remiss if it did not address the continued increase in the Company’s market capitalization and the implications that has for the future.

Without a doubt the Company’s market capitalization suffered, as did many other companies, in the general Covid-19 market meltdown at the end of March 2020. However, PyroGenesis soon broke from the pack with the issuance of a material press release on March 24th, 2020.

Management believes that its breaking from the ranks caught the attention of investors, fund managers, and money managers who all now had the time during the COVID-19 lockdown to fully analyze the complicated story that is PyroGenesis. Management does not see any reason why this interest would abate anytime soon. To the contrary, Management has reason to believe that interest in the Company will only increase over the foreseeable future. As such, several strategies (up listings, spinoffs, acquisitions) are now being accelerated/considered.

Having a larger market capitalization has also helped in discussions with potential customers who take comfort from the possibility that a higher market capitalization may translate into easier access to capital. For the record, there is no intention to raise capital for working capital purposes.

If 2018 was the year in which PyroGenesis successfully positioned each of its commercial business lines by strategically partnering with multi-billion-dollar entities, and 2019 was the year that saw the appropriate personnel and infrastructure being put in place while building upon the success of 2018, then 2020 is without a doubt the year that  the long awaited breakout, which began in the second half of 2019, takes place; it is in fact already upon us:

To date during 2020, PyroGenesis has:

  1. received significant payments under the $22MM contract with Drosrite International thereby validating announcements made during 2019,

  2. established a relationship with a US based tunneling company (contracts and payments ongoing),

  3. Established itself in the iron ore pelletization industry as a potential supplier of torches geared to replacing existing burners and thereby reducing GHGs. Interest is also spilling over into other industries with GHG reduction targets,

  4. Established a relationship with an OEM in North America with the intent to eventually supply powders for their 3D printing needs. This augments our relationship with Aubert & Duval, while at the same time de-risking our dependence on them,

  5. retired the $3MM convertible debenture in full,

  6. bought back approximately 1.2 Million shares under the existing Normal Course Issuer Bid,

  7. increased Company’s investment in HPQ, who has subsequently also experienced a significant increase in market capitalization,

  8. further benefited from early conversions of warrants maturing in 2021 of over $3MM. 

The Company has booked a significant backlog of signed contracts (in excess of $28MM; 2019 Revenues approx. $5MM) which, when taking the eagerly awaited US Navy contract into account, will increase to over $38MM. This provides a solid cornerstone upon which PyroGenesis can:

  1. continue to build on the recent successes with the Company’s DROSRITE™ offering,

  2. Leverage off of the recent successes with the Company’s torch offerings to (i) the iron ore pelletization industry, and (ii) a tunneling client,

  3. Accelerate activities with Aubert & Duval in the Additive Manufacturing sector as well as HPQ in the Mining and Metallurgical sector, both of which did not progress as fast as management would have liked in 2019. Significant attention will be placed on both these activities in 2020.

Specifically, with Aubert & Duval the goal will be to complete the integration of the cutting-edge advances PyroGenesis has made to the powder production process.

With respect to HPQ, the goal would be to accelerate the game changing PUREVAP™ family of processes which we are developing for HPQ, namely:

  • The PUREVAP™ “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential; and
  • The PUREVAP™ Nano Silicon Reactor (NSiR), a new proprietary process that use PUREVAP™ QRR silicon (Si) as feedstock, to make spherical silicon nano powders and nanowires;

Looking forward, the Company has, as of December 31st, 2019, approximately $10MM of in-the-money warrants and options expiring in 2020 and 2021. The Company also has over $50MM in tax loss carryforwards (roughly evenly distributed between federal and provincial obligations) which is not reflected as an asset on the balance sheet. 

Financial Summary

Revenues

PyroGenesis recorded revenue of $2,128,454 in the second quarter of 2020, representing an increase of 133% compared with $913,769 recorded in the second quarter of 2019.

Revenues recorded in the three and six months ended June 30, 2020 were generated primarily from:

  1. DROSRITE™ related sales of $1,319,904 (3 months) and $1,794,336 (6 months),
  2. PUREVAP™ related sales of $25,093 (3 months) and $43,058 (6 months),
  3. torch related sales of $617,077 (3 months) and $705,022 (6 months),
  4. support services related to PAWDS-Marine systems supplied to the US Navy $37,143 (3 months) and $61,039 (6 months).

Cost of Sales and Services and Gross Margins

Cost of sales and services before amortization of intangible assets was $855,049 in Q2 2020, representing an increase of 18% compared with $723,641 in Q2 2019, primarily due to an increase in subcontracting and direct material expenses offset by a reduction in employee compensation in Q2 2020.

In Q2 2020, employee compensation decreased to 103,957 (Q2 2019 – $414,873) and subcontracting, direct materials and manufacturing overhead increased to $813,201 (Q2 2019 – $335,240). The gross margin for Q2 2020 was $1,268,592 or 59.5% of revenue compared to a gross margin of $185,349 or 20.3% of revenue for Q2 2019. As a result of the type of contracts being executed, the nature of the project activity, as well as the composition of the cost of sales and services, as the mix between labour, materials and subcontracts may be significantly different. Of note, the Company in Q2 2020 applied for an amount of $648,125 in wage subsidy from Revenue Canada under the CEWS program. From this amount, $92,028 was applied to employee compensation under cost of sales and services.

Investment tax credits recorded against cost of sales are related to projects that qualify for tax credits from the provincial government of Quebec. Qualifying tax credits decreased to $18,758 in Q2 2020, compared with $29,061 in Q2 2019. This represents a decrease of 35% year-over-year. In total, the Company earned refundable investment tax credits of $17,332 in Q2 2020. The Company continues to make investments in research and development projects involving strategic partners and government bodies.

The amortization of intangible assets of $6,813 in Q2 2020 and $4,779 for Q2 2019 relates to patents and deferred development costs. Of note, these expenses are non-cash items and will be amortized over the duration of the patent lives.

Selling, General and Administrative Expenses

Included within Selling, General and Administrative expenses (“SG&A”) are costs associated with corporate administration, business development, project proposals, operations administration, investor relations and employee training.

SG&A expenses for Q2 2020 excluding the costs associated with share-based compensation (a non-cash item in which options vest principally over a four-year period), were $1,641,338 representing an increase of 4% compared with $1,583,779 reported for Q2 2019. 

The increase in SG&A expenses in Q2 2020 over the same period in 2019 is mainly attributable to the net effect of:

  • an increase of 34% in employee compensation due primarily to an increase in commission expenses offset by amounts claimed from Revenue Canada under the CEWS wage subsidy program,
  • an increase of 15% for professional fees, primarily due to an increase in legal fees,
  • a decrease of 0.4% in office and general expenses, is due to a decrease in computer and internet expenses,
  • travel costs decreased by 82%, due to a decrease in travel abroad,
  • depreciation on property and equipment decreased by 79% due to lower amounts of property and equipment being depreciated,
  • depreciation on right of use assets decreased by 19% due to lower amounts of right of use assets being depreciated,
  • Investment tax credits increased by 328% due to an additional refund of $24,605 from the 2018 tax return filed,
  • government grants increased by 228% due to higher levels of activities supported by such grants,
  • other expenses decreased by 33%, primarily due to a decrease in cost of freight and shipping.

Separately, share based payments decreased by 14% in Q2 2020 over the same period in 2019 as a result of the vesting structure of the stock option plan including the stock options granted on January 2, 2020.

Research and Development (“R&D”) Costs

The Company incurred ($3,869) of R&D costs, net of government grants, on internal projects in Q2 2020, a decrease of 102% as compared with $212,645 in Q2 2019. The decrease in Q2 2020 is primarily related to an increase in government grants supporting our R&D activities and an amount of $129,201 claimed under the wage subsidy from Revenue Canada under the CEWS program.

In addition to internally funded R&D projects, the Company also incurred R&D expenditures during the execution of client funded projects. These expenses are eligible for Scientific Research and Experimental Development (“SR&ED”) tax credits. SR&ED tax credits on client funded projects are applied against cost of sales and services (see “Cost of Sales” above). 

Net Finance Costs

Finance costs for Q2 2020 totaled $276,928 as compared with $275,418 for Q2 2019, were less than 1%, resulting in a virtually unchanged variance.

Strategic Investments

The adjustment to the fair market value of strategic investments for Q2 2020 resulted in a gain of $5,899,465 compared to a loss in the amount of $339,313 in Q2 2019, representing an increase of 1839% year-over-year. The increase is primarily attributable to the increased market share value in the HPQ Silicon Resources Inc. and Beauce Gold Fields.

Net Comprehensive Loss

The net comprehensive gain for Q2 2020 of $5,228,020 compared to a loss of $2,253,390, in Q2 2019, represents an increase of 332% year-over-year. The increased gain of $7,481,410 in the comprehensive gain in Q2 2020 is primarily attributable to the factors described above, which have been summarized as follows:

  1. an increase in product and service-related revenue of $1,214,685 arising in Q2 2020, an increase in cost of sales and services totaling $133,442, primarily due to an increase in subcontracting, direct materials, manufacturing overhead & other, offset by a decrease in employee compensation,
  2. an increase in SG&A expenses of $53,613 arising primarily due to an increase in employee compensation, professional fees, offset by a decrease in travel, depreciation on property and equipment, depreciation ROU assets, and other expenses,
  3. a decrease in R&D expenses of $216,512 primarily due to an increase in government grants and wage subsidy,
  4. an increase in net finance costs of $1,510 primarily due to interest on higher amounts of debt,
  5. an increase in fair value adjustment of $6,238,778 primarily due to strategic investments.    

EBITDA

The EBITDA gain in Q2 2020 was $5,610,023 compared with an EBITDA loss of $1,814,832 for Q2 2019, representing an increase of 409% year-over-year. The $7,424,855 increase in the EBITDA gain in Q2 2020 compared with Q2 2019 is due to the increase in comprehensive income of $7,418,410, a decrease in depreciation on property and equipment of $38,927, a decrease in depreciation of right of use assets of $21,171, an increase in amortization of intangible assets of $2,034, and an increase in finance charges of $1,511.

Adjusted EBITDA gain in Q2 2020 was $5,633,661 compared with an Adjusted EBITDA loss of $1,787,248 for Q2 2019. The increase of $7,420,909 in the Adjusted EBITDA gain in Q2 2020 is attributable to an increase in EBITDA gain of $7,424,855, offset by a decrease of $3,946 in share-based payments.

The Modified EBITDA loss in Q2 2020 was $265,804 compared with a Modified EBITDA loss of $1,447,935 for Q2 2019, representing a decrease of 82%. The decrease in the Modified EBITDA loss in Q2 2020 is attributable to the increase as mentioned above in the Adjusted EBITDA of $7,357,909 and an increase in the change of fair value of strategic investments of $6,238,778.

Liquidity

The Company has incurred, in the last several years, operating losses and negative cash flows from operations, resulting in an accumulated deficit of $57,304,682 and a negative working capital of $7,463,370 as at Q2 2020, (December 31, 2019 – $60,237,656 and $10,492,102 respectively). Furthermore, as at Q2 2020, the Company’s current liabilities and expected level of expenses for the next twelve months exceed cash on hand of $1,567,777 (December 31, 2019 – $34,431). The Company has relied upon external financings to fund its operations in the past, primarily through the issuance of equity, debt, and convertible debentures, as well as from investment tax credits.

Revenue generated from active projects has begun to produce sufficient positive cash flow to fund operations. The Company has a strong backlog from signed contracts totaling $28MM, and a pipeline of prospective new projects resulting in the Company’s business plan becoming less dependent on raising additional funds to finance operations within and beyond the next 12 months. While the Company has been successful in securing financing in the past, raising additional funds is dependent on a number of factors outside the Company’s control, and as such there is no assurance that it will be able to do so, should it need to, in the future. If the Company is unable to obtain sufficient additional financing when needed, it may have to curtail operations and development activities, any of which could harm the business, financial condition and results of operations.

About PyroGenesis Canada Inc.
PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]
RELATED LINK: http://www.pyrogenesis.com/

Spyder Cannabis $SPDR.ca Announces Final Approvals to Open Niagara Falls and Calgary Cannabis Dispensaries $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:40 AM on Wednesday, July 29th, 2020
  • Announced that its dispensary located at 6474 Lundy’s Lane, passed its final inspection on July 27, 2020, and intends to open for business in the first week of August 2020
  • Also announced that its dispensary located at #140, 104 – 58 Avenue SE, was formally issued a Retail Cannabis Store License (No. 781144-1) and intends to open for business in August 2020

Vaughan, Ontario–(July 29, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to provide the following update:

Niagara Falls and Cannabis Dispensary

The Company is pleased to announce that its dispensary located at 6474 Lundy’s Lane, passed its final inspection on July 27, 2020, and intends to open for business in the first week of August 2020.

Calgary Cannabis Dispensary

The Company is also pleased to announce that its dispensary located at #140, 104 – 58 Avenue SE, was formally issued a Retail Cannabis Store License (No. 781144-1) and intends to open for business in August 2020.

“Both dispensaries are located in busy commercial hubs, in their respective cities. The Spyder team is excited to commence operations and bring its best of class customer service and retail experience to both cities”, stated Dan Pelchovitz, the Company’s CEO.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of Hemp CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain ‘forward-looking information” within the meaning of applicable securities laws (‘forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

For additional info, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737
Email: [email protected]

Candente Gold Corp. $CDG.ca Launches AGORACOM Online Marketing as Primary Investor Social Media Discussion Platform

Posted by AGORACOM at 8:20 AM on Wednesday, July 29th, 2020

VANCOUVER, British Columbia, July 29, 2020 (GLOBE NEWSWIRE) — Candente Gold Corp. (TSXV:CDG) (“Candente Gold” and/or the “Company”) is pleased to announce the launch of a “CEO Verified” Discussion Forum on AGORACOM. The forum will serve as the Company’s primary social media platform to interact with both shareholders and the broader investment community in a fully moderated environment.

The Candente Gold HUB is live and can be found at: https://agoracom.com/ir/CandenteGold

Candente Gold will also receive significant exposure through millions of content brand insertions on the AGORACOM network and extensive search engine marketing over the next 12 months. In addition, exclusive sponsorships of invaluable digital properties such as the AGORACOM home page and the AGORACOM Twitter account will serve to significantly raise brand awareness of the Company among small cap investors. AGORACOM is the only small cap marketing firm to hold a Twitter Verified badge, averaging 4.2 million Twitter impressions per month in 2019.

Moderated Discussion for Candente Gold Management and Shareholders

AGORACOM “CEO Verified” provides the first ever identity verification of small cap executives on a finance platform.  Small cap CEO’s and other company officers are now able to post or communicate within a discussion forum without the risk of impersonation.  As the ultimate influencers of their own companies, “CEO Verified” forums create unmatched levels of engagement between companies and investors that have long desired civilized, constructive and factual conversation.

Posts to AGORACOM are shareable on Twitter, Facebook and LinkedIn, which provides Management with one-click sharing of valuable content to these social media platforms, with automatic links back to AGORACOM for civilized investor engagement. 

There are no log-in requirements for investors to visit the forum, read posts and share company posts with their networks on other platforms.  Investors wishing to post questions, comments and interact with company officers can quickly log-in using their Facebook or LinkedIn accounts, or create an anonymous new user account.

The Candente Gold Forum can be found at: https://agoracom.com/ir/CandenteGold/profile

Verified Candente Gold Officer at Launch

  • Joanne Freeze, President, CEO and Director

Joanne Freeze, President and CEO stated, “Social media participation is very important for growth companies such as ours and AGORACOM forums are purpose built to facilitate intelligent discussion without the nonsense that plagues other such sites.  I encourage everyone to read and participate in our CEO Verified Discussion Forum to create vibrant and constructive discussions for the long term benefit of everyone.”

George Tsiolis, AGORACOM Founder stated: “With gold prices hitting record highs and conditions looking favourable for continuation over the next three years, small cap investors are looking for high quality companies to grow with in this cycle. Candente Gold’s strategy to build cash flowing assets couldn’t come at a better time and we can’t wait to tell their story to the world.”

Term and Compensation

TERM: July 15, 2020 – July 15, 2021

FEES: $CDN 60,000 + HST*

  • $60,000 + HST to be paid via Shares For Services Under TSX Venture Policy 4.3 (Section 5)

  • $12,000 + HST Shares For Services upon Commencement July 15, 2020 for initial set up of HUB, marketing materials and search engine programs.

  • $12,000 + HST Shares For Services at end of Third Month October 15, 2020

  • $12,000 + HST Shares For Services at end of Sixth Month January 15, 2020

  • $12,000 + HST Shares For Services at end of Ninth Month April 15, 2021

  • $12,000 + HST Shares For Services at end of Twelfth Month July 15, 2021 

Per TSX Venture Policy 4.3 (Section 6.1), the deemed price of the securities to be issued will be determined after the date services are provided to advertiser in each period and are to be calculated using the closing price on each date above. Share issuances to AGORA under this Shares For Services Agreement will be effected pursuant to the “consultant exemption” contained in Section 2.24 of National Instrument 45-106 Prospectus Exemptions. To qualify as a consultant with this exemption, the consultant must be engaged to provide services to the issuer, pursuant to a written contract, other than services provided in relation to a distribution and must spend a significant amount of time and attention on the affairs and business of the issuer.

About Candente Gold

Candente Gold has launched a comprehensive growth strategy to build a cash flowing business platform and gain access to properties with near surface exploration potential while maintaining El Oro as its flagship asset and an integral part of the overall growth strategy.  The acquisition of the SDA Plant and the El Dorado historic mines signifies an important first step.

The financial benefits from Western Mexico operations and the addition of specialized personnel will translate across platforms to strengthen our efforts to explore and potentially mine.  The Company is currently evaluating properties that are complimentary to the SDA plant and El Dorado Property. 

El Oro is a district scale gold project encompassing a well-known prolific high-grade gold dominant gold-silver epithermal vein system in Mexico.  The project covers 20 veins with past production and more than 57 veins in total, from which approximately 6.4 million ounces of gold and 74 million ounces of silver were reported to have been produced from just two of these veins (Ref. Mexico Geological Service Bulletin No. 37, Mining of the El Oro and Tlapujahua Districts. 1920, T. Flores*)

Modern understanding of epithermal vein systems indicates that several of the El Oro district’s veins hold excellent discovery potential, particularly below and adjacent to the historic workings of the San Rafael Vein, which was mined to an average depth of only 200 metres. 

Joanne C. Freeze, P.Geo., President, CEO and Director and Matthew Melnyk, CPG., Director Operations are Qualified Persons as defined by National Instrument 43-101 for the projects discussed above.  Ms. Freeze and Mr. Melnyk have reviewed and approved the contents of this release.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

About AGORACOM

AGORACOM is the pioneer of online marketing, broadcasting, conferences and investor relations services to North American small and mid-cap public companies, with more than 300 companies served. AGORACOM is the home of more than 7.7 million investors that visited 55.2 million times and read over 600 million pages of information over the last 10 years. The average visit of 8min 43sec is more than double that of global financial sites, which can be attributed to the implementation and enforcement of the strongest moderation rules in the industry.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Forward-looking Information
This news release may contain forward-looking information (as such term is defined under Canadian securities laws) including but not limited to information regarding the potential for discovery in the El Oro district and other statements that are not historical facts.  While such forward-looking information is expressed by Candente Gold in good faith and believed by Candente Gold to have a reasonable basis, they address future events and conditions and are therefore subject to inherent risks and uncertainties including those set out in Candente Gold’s MD&A.  Factors that cause the actual results to differ materially from those in forward-looking information include, without limitation, gold prices, results of exploration and development activities, regulatory changes, defects in title, availability of materials and equipment, timeliness of government approvals, potential environmental issues, availability of capital and financing and general economic, market or business conditions. Candente Gold expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except in accordance with applicable securities laws.

On behalf of the Board of Candente Gold Corp.
“Joanne Freeze” P.Geo.

For further information please contact:

Joanne FreezePresident & CEO+1 (604) 689-1957
[email protected]

Loop Insights $MTRX.ca Adds Jeffrey Hyman To Board Of Directors With Over 20 Years Experience With Tier-1 Wall Street Firms $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 7:19 AM on Wednesday, July 29th, 2020
Loop Insights – Medium
  • Announced the appointment of Jeffrey Hyman to the Company’s Board of Directors. Jeffrey previously served on the Board of Advisors
  • Jeffrey brings a high level of capital markets knowledge, with over 20 years of experience in Wall Street investment banking and financial advisory

VANCOUVER, BC, July 29, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive automated marketing, contact tracing, and contactless solutions to the brick and mortar space, is pleased to announce the appointment of Jeffrey Hyman to the Company’s Board of Directors. Jeffrey previously served on the Board of Advisors.

HYMAN BRINGS OVER 20 OF EXPERIENCE WITH TIER-1 WALL STREET FIRMS

Jeffrey brings a high level of capital markets knowledge, with over 20 years of experience in Wall Street investment banking and financial advisory.  As a Managing Director, he ran practice groups at bulge bracket firms, and also served on the Technology Committee at J.P. Morgan Chase’s Investment Bank. At Guggenheim Partners, Jeff was Global Co-Head of Municipal, Project and Infrastructure Finance. He also brings experience leading large-scale development and redevelopment projects in the US. With previous projects in industries such as hospitality and entertainment, casino and gaming, destination and resort, and public infrastructure projects—Jeffrey’s portfolio aligns well with Loop’s target clients and industries.

Jeffrey Hyman stated “I have always been drawn to the next big thing, whether it is through investment or project development. Since my appointment to the Board of Advisors in April, Loop has not only stayed relevant, it has caught fire— as demonstrated by recent high-profile announcements. It’s clear that there is a place for Loop’s solution in many lucrative industries; I plan on lending my expertise and leveraging my connections to accelerate the company’s expansion into the global market.”

Loop CEO, Rob Anson stated “Jeffrey’s capital markets knowledge comes at a pivotal time, as we begin to gain significant attention from investors on both sides of the border, as well as, national and international organizations that are rapidly interested in deploying our technology.  We’re lucky to have Jeffrey on our Board of Directors to support our growth in capital markets, as well as, expand our business into the industries of hospitality and resort, sports and entertainment, and casino gaming.”

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion and Q&A https://agoracom.com/ir/LoopInsights/forums/discussion

About Loop Insights: Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.

Forward-Looking Statements/Information: 

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives. 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE LOOP Insights Inc.

VIDEO: Else Nutrition $BABY.ca Begins Selling Plant-Based Products For US Toddlers Market $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 4:18 PM on Tuesday, July 28th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

When the subsidiary of a Billion Dollar, Nutrition Focused company buys 11.5% of your stock, agrees to a voluntary 12-month lock up and holds anti-dilution rights to maintain it’s ownership percentage by buying a proportionate number of shares in any future financing, it is safe to assume you have a strategic investor who believes in the future of your company.

When that same strategic investor wants to then help your company expand into large international markets, it is safe to assume your plant based food capabilities are amongst the most respected in the world.

This is just a glimpse into the strength of Else Nutrition (BABY:TSXV) (BABYF:OTCQB), an Israeli based, award winning plant based food nutrition company that is giving small cap investors an opportunity to participate in the global paradigm shift towards plant-based, clean label foods.US MARKET COMMERCIALIZATION COMMENCES

Given what you now know, it should come as no surprise that – as part of its path to commercialization in the U.S.A. – it has just successfully completed its first full-scale commercial production run of its Plant-based Toddler Nutrition product. The production run was completed at the U.S. based facilities of the Company’s production partner, a leading producer of organic baby formula in the U.S.   BABY CEO Hamutal Yitzhak stated “These accomplishments further demonstrate our readiness for launch into the North American marketplace.Parents across North America have been looking for clean, plant-based, whole food nutrition options for their children – and we are set to make this a reality” “Making it a reality”appears imminent because the company has signed broker agreements with three (3) reputable, natural food retail brokers, and is close to signing with a fourth broker.  Moreover, pre-orders are already commencing online.  In short, BABY is on the proverbial commercial launch pad into a paradigm shifting industry that itself is also on the launch pad for the 2020 decade – Plant Based, Clean Label Foods.   

If you believe in the future of plant-based, clean label foods or want to discover its possibilities, then watch this incredible interview with CEO Hamutal Yitzhak.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Datametrex $DM.ca Appoints Hon. James S. Peterson, P.C.

Posted by AGORACOM-JC at 11:01 AM on Tuesday, July 28th, 2020
  • Announced the appointment of Hon. James S. Peterson, P.C., as a new independent member of the Board of Directors
  • Hon. Peterson is a former federal Cabinet Minister and Secretary of State, with extensive knowledge and first-hand experience legal, financial, board governance and government affairs

TORONTO, July 28, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Hon. James S. Peterson, P.C., as a new independent member of the Board of Directors. Hon. Peterson is a former federal Cabinet Minister and Secretary of State, with extensive knowledge and first-hand experience legal, financial, board governance and government affairs.

“I want to thank our newest Board Member for taking on the position of Director at Datametrex,” said CEO, Marshall Gunter. “His diplomacy and global business acumen are critical assets to better position us in the market, so that we can operate at the highest level in this changing environment. We continue striving for increased collaboration with new consortia in the preventive technologies industries around the world.”

Jim Peterson with his government experience on the world stage brings a wealth of knowledge in strategic planning and government affairs. He will be using this experience in helping Datametrex engage with world governments to bring more testing to the general population to eradicate the spread of the COVID-19 virus. 

Jim obtained his BA and LLB from Western University, his LLM from Columbia University and his DCL from McGill University. He also taught Law at University of Toronto, and worked for the UN International development organization in Vienna, Khartoum, and Kuala Lumpur on International joint business ventures in developing countries. He is a Member of the Ontario Bar Association, the Canadian Bar Association, and is a Co-Chair of the Canada-US Law Institute. Jim has also served for the Government of Canada as Minister of International Trade, Secretary of State (International Financial Institutions), and Chair of the House of Commons Standing Committee on Finance. While a Cabinet Minister, Jim represented Canada at the World Trade Organization’s Doha round of negotiations, which were focused on expanding trade and investment in leading emerging markets Brazil, Russia, India and China, and with complex issues related to trade with Canada’s NAFTA partners, the European Union, the Middle East and the Americas.

Jim served as Chair of the House of Commons Finance Committee where he began the practice of public pre-budget hearings and completed several major studies including a review of Canada’s value added tax (the GST). He retired from the House of Commons in 2007 after 23 years of public service as the Member of Parliament for Willowdale (Toronto).

“I am a firm believer that time is a resource that companies in high-growth mode cannot afford to waste,” Hon. Peterson said. “Datametrex is certainly among those companies. I am honoured to join the Board of this thriving Company; I look forward to further contribute to the strong innovative systems that make a difference in our society.”

The company has issued Jim 1,000,000 options.

As part of the Board changes, the Company announces that David Ellison is stepping down from the Board of Directors to make room for Jim, and will be joining the Advisory Board to continue supporting Datametrex with his legal expertise. Datametrex thanks David for his efforts and for still serving Datametrex to help solve the Company’s most pressing challenges.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email:  [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Else Nutrition $BABY.ca Completes Successful Toddler Nutrition U.S. Production Run and Opens Online Store for Pre-Orders $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:23 AM on Tuesday, July 28th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced that as part of its path to commercialization in the U.S., it has recently completed its first full-scale commercial production run of its Plant-based Toddler Nutrition product
  • The manufacturing run was successfully completed, meeting a rigorous set of quality standards
  • Additionally, the Company has launched pre-orders on its e-store (www.elsenutrition.com)
  • Customers in the U.S. and Canada can now place pre-orders, for delivery next month

VANCOUVER, BC / July 28, 2020 / Else Nutrition Holdings Inc. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company”), is pleased to announce that as part of its path to commercialization in the U.S., it has recently completed its first full-scale commercial production run of its Plant-based Toddler Nutrition product. The manufacturing run was successfully completed, meeting a rigorous set of quality standards. The production run was completed at the U.S. based facilities of the Company’s production partner, a leading producer of organic baby formula in the U.S.

Additionally, the Company has launched pre-orders on its e-store (www.elsenutrition.com). Customers in the U.S. and Canada can now place pre-orders, for delivery next month.

“These accomplishments further demonstrate our readiness for launch into the North American marketplace,” said Ms. Hamutal Yitzhak, CEO and Co-Founder of Else. “Parents across North America have been looking for clean, plant-based, whole food nutrition options for their children – and we are set to make this a reality.”

“Finding the right balance of healthy foods to promote optimal childhood growth and development can be a challenge for many parents. Else’s Plant-based toddler nutritional drink is clean nutrition , minimally-processed product, providing the appropriate vitamins and minerals content, plant-based proteins, and healthy fats and carbs . With so many available foods that are low in nutritional value, this product is a welcome addition to the market,” said Dr. Leah Alexander, Pediatrician, MD, FAAP.

Last month, Else began offering samples of its Plant-based Toddler Nutrition product on its site, receiving highly favorable customer reviews, “loving the clean, minimally processed ingredients” and welcoming a “healthier alternative.”

Customers in the U.S. and Canada can pre-order the full-sized Else Nutrition Plant-Based Complete Nutrition for Toddlers (in single and 4-pack offerings) on the Else e-store at: www.elsenutrition.com. A single 22 oz. product is available at the introductory price of USD$36, with a 4-pack priced at USD$136. Shipping in the Continental U.S. is free during the launch.

About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For additional information, contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others Forward-looking statements made in this press release assume, among others, the timing of the Company’s toddler nutrition product launch and the availability of the Company’s product online. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Esports Entertainment Group $GMBL Appoints Jeff Cohen as VP Strategic Planning and IR $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 7:17 AM on Tuesday, July 28th, 2020
  • Appointed Jeff Cohen as Vice President Strategic Planning and IR
  • Cohen was previously an equity analyst covering gaming and esports for Stephens Inc., a leading Wall Street investment bank and asset manager

BIRKIRKARA, Malta, July 28, 2020 — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, appointed Jeff Cohen as Vice President Strategic Planning and IR.

Cohen was previously an equity analyst covering gaming and esports for Stephens Inc., a leading Wall Street investment bank and asset manager. Frequently quoted by the Wall Street Journal, Reuters, CNBC and The Fly, Cohen has appeared on CheddarTV and several prominent gaming industry podcasts and maintains relationships with major buyside investment firms. Prior to joining Stephens in 2017, Cohen was an analyst in the Equity Special Situations Group at Barclays. Cohen earned his Bachelor’s in Government at Harvard University and an MBA in Finance and Accounting from Columbia Business School.

“We are thrilled to welcome Jeff to our team,” commented Grant Johnson, CEO of Esports Entertainment Group. “He’s been a leading analyst in the gaming and esports arena, and his wealth of knowledge and relationships with major buyside players are great assets for us as we continue to execute on our growth strategy.”

Cohen stated, “I am excited to join the Esports Entertainment team and look forward to providing value as we work to capitalize on multiple opportunities in the rapidly evolving global esports market.”

ABOUT ESPORTS ENTERTAINMENT GROUP

Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fantasy, pools, fixed odds and exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at vie.gg.  In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands. The Company maintains offices in Malta. For more information visit www.esportsentertainmentgroup.com

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations 
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Media & Investor Relations Inquiries
AGORACOM
[email protected] 
http://agoracom.com/ir/eSportsEntertainmentGroup

Empower Clinics $CBDT.ca Reports Q1 2020 Results with 416% Revenue Increase $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:14 AM on Tuesday, July 28th, 2020
  • 5,717 patient visits generating total revenue of $789,135, compared to 1,198 patient visits generating $152,846 for Q1 2019

VANCOUVER, BC / July 28, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTCQB:EPWCF) (Frankfurt:8EC)(“Empower” or the “Company“) has filed today its unaudited interim condensed consolidated financial statements and related management’s discussion and analysis, both of which are available at www.SEDAR.com. All financial information in this press release is reported in United States dollars, unless otherwise indicated.

“Our strong Q1 2020 performance is a direct reflection of the numerous changes and improvements from 2019, setting in motion a framework for sustained growth.” said Steven McAuley, Chairman and CEO. “Our Sun Valley Health division started the year with record patient visits and now offers more diversified wellness services, adding new revenue sources and a more diversified business model.”

Q1 2020 Highlights

  • 5,717 patient visits generating total revenue of $789,135, compared to 1,198 patient visits generating $152,846 for Q1 2019.
  • Net loss of $524,208 or $0.00 per share, compared to $398,541 or $0.01 per share for Q1 2019, which was primarily driven by increased non-cash accretion expense.
  • Cash provided by operating activities was $13,864, compared to cash used by operating activities of $219,212 for Q1 2019.
  • Cash at March 31, 2020 of $131,808, compared to cash of $179,152 at December 31, 2019.

Recent Highlights Subsequent to Quarter End

  • Private Placement: Empower Clinics closes private placement of $653,000 CAD in April 2020 and $720,866 CAD in July 2020 to support growth initiatives.
  • Psychedelics Division: May 2020 Empower enters into a term sheet to acquire an interest in the global royalty rights of Dosed Movie, launches Dosed Wellness, a psychedelics brand, launches new dedicated website www.dosedwellness.com and adds new team members dedicated to the new brand.
  • COVID-19 Testing: April 2020 the Company launches a four-phase roll-out of COVID-19 testing in clinics and onsite for businesses.
  • Cannvas Education Platform: May 2020 Empower and EuroLife Brands complete definitive agreement for multi-year, multi-national licence of EurolIfe’s cannvas.me web-based education technology platform to deliver brand, product, and industry knowledge to the market.

Financial Summary

$, except where notedThree months ended March 31,
 20202019 
Patient visits (#)5,7171,198 
Clinic Revenues767,803152,846 
Direct Clinic Expenses256,42239,413 
Loss from operations(317,831)(279,308) 
Net loss(524,208)(398,541) 
Net loss per share(0.00)(0.01) 

Financial Performance

Clinic revenues for Q1 2020 and Q1 2019 were $767,803 and $152,846, respectively. This increase above prior year is attributable to the acquisition of Sun Valley and the addition of 5 clinics which drove an increase in patient count from 1,198 in Q1 2019 to 5,717 in Q1 2020.

Direct clinic expenses for Q1 2020 and Q1 2019 were $256,422 and $39,413, respectively. This increase above prior year is attributable to the increase in number of patient visits.

Net loss from operations for Q1 2020 and Q1 2019 were $317,831 and $279,308, respectively. This increase above prior year is primarily attributable to an increase in salaries and benefits with the acquisition of Sun Valley. This decrease was partially offset by an increase in clinic revenues with the acquisition of Sun Valley.

Net loss for Q1 2020 and Q1 2019 were $524,208 and $398,541, respectively. This increase over prior year is primarily attributable to non-cash accretion expense related to the convertible debentures.

During the three months ended March 31, 2020, the Company generated $13,864 in cash from operations after changes in non-cash working capital. The Company used $61,209 for payment of lease liabilities.

Please refer to the Company’s unaudited condensed interim consolidated financial statements for the three months ended March 31, 2020 and 2019, and accompanying Management Discussion and Analysis for a full review of the operations.

About Empower

Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.

ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer

CONTACTS:

InvestorsDustin Klein Steven McAuley
 Director CEO
 720-352-1398 604-789-2146
 [email protected] [email protected]

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding the direction and growth prospects of the Company, the expansion of the company’s clinic and distribution network, the expected effect of the Vendors in their new roles with the Company, the effect on the lives of patients, the growth into a national brand, the effect of the Transaction, the diversification of the Company’s business model, the potential appeal to shareholders, the growth of the Company’s patient list and the effect thereof, the expected benefits for the company’s patient base and customers, the release of the cash consideration, the release of Shares being held in escrow in connection with the Transaction and statements regarding the Company’s proprietary product line “Sollievo”. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that the Company may not be able to expand, that the Transaction may not have the expected results, and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

TransCanna’s $TCAN.ca First Commercial Batch of World Class Cannabis Concentrates in Collaboration with the Summit Boys Available in Stores This Week $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:11 AM on Tuesday, July 28th, 2020
tcan-square

  • First batch of its cannabis concentrate products that is being co-branded with award-winning product producer, the Summit Boys, will be available for purchase this week
  • Lyfted Farms Inc. (a TransCanna subsidiary) is now supplying high-quality-cannabis ‘trim’ (a by-product of cannabis flower production) to the Summit Boys for processing into an already popular line of cannabis concentrates branded as ‘Caviar’

Vancouver, British Columbia–(July 28, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) TransCanna announces that the first batch of its cannabis concentrate products that is being co-branded with award-winning product producer, the Summit Boys, will be available for purchase this week.

Lyfted Farms Inc. (a TransCanna subsidiary) is now supplying high-quality-cannabis ‘trim’ (a by-product of cannabis flower production) to the Summit Boys for processing into an already popular line of cannabis concentrates branded as ‘Caviar.’ These retail products now also include innovative packaging featuring a ‘window’ to showcase the superior color and texture of the concentrates.

Cannabis concentrates have a greater proportion of cannabinoids and terpenes when compared to natural cannabis flowers, and can increase the potency of cannabis flower. Demand for these concentrates are also the fastest-growing of any cannabis product in the California market (the largest Cannabis market globally.)

The Summit Boys are a well-known legacy recreational cannabis product producer with a cult-like following on Instagram of over 66,000 followers. In 2019, the Summit Boys earned over 14 Bay Area Cannabis Cup awards in several categories, including for Best Product and Hybrid Concentrate.

“The sale of these products is the first exciting step in our distribution plan to bring a higher-quality product to market by aligning with California’s most reputable industry partners, said Bob Blink, TransCanna CEO, adding that consumers recognize the Summit Boys for their quality of product and processing superiority. This collaboration also increases our profit margin for each harvest by converting trim, which can be valued as low as USD $0.15 per gram, into a refined finished product that wholesales for USD $17.00 per gram.”

“Our goal has always been to make the best tasting and smelling products that drive customers to come back for what we have to offer. Now that we are using even higher quality trim from Lyfted Farms we can’t wait to see how our customers react,” said Mike Larson, the Summit Boys CEO. “This is the best product that we’ve ever produced. Fire into the process equals fire out.”

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed Company building cannabis-focused brands for the California lifestyle through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors
Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements referred to herein as “forward-looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that operations will commence at the Company’s Daly facility in Modesto, California, as and when expected.

These forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially from any future results, events or developments expressed or implied by such forward-looking statements. Risks and uncertainties associated with the forward-looking information in this news release include, among others, dependence on obtaining and maintaining regulatory approvals, including state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete upgrades to its Daly facility in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; reliance on management; and the effect of capital market conditions and other factors (including those related to the COVID-19 pandemic) on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look, except in accordance with applicable securities laws.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN